The global market for Dutasteride was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.

North American market for Dutasteride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dutasteride is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dutasteride include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex, Marksans Pharma, Breckenridge Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dutasteride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dutasteride.

The Dutasteride market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dutasteride market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dutasteride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dutasteride Market Report

Report Metric	Details
Report Name	Dutasteride Market
Segment by Type	Type I Type II
Segment by Application	Hospital Drug Store
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex, Marksans Pharma, Breckenridge Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dutasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dutasteride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dutasteride Market report?

Ans: The main players in the Dutasteride Market are GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex, Marksans Pharma, Breckenridge Pharmaceutical

What are the Application segmentation covered in the Dutasteride Market report?

Ans: The Applications covered in the Dutasteride Market report are Hospital, Drug Store

What are the Type segmentation covered in the Dutasteride Market report?

Ans: The Types covered in the Dutasteride Market report are Type I, Type II

1 Dutasteride Market Overview

1.1 Product Definition

1.2 Dutasteride by Type

1.2.1 Global Dutasteride Market Value Comparison by Type (2024 VS 2031)

1.2.2 Type I

1.2.3 Type II

1.3 Dutasteride by Application

1.3.1 Global Dutasteride Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Drug Store

1.4 Global Dutasteride Market Size Estimates and Forecasts

1.4.1 Global Dutasteride Revenue 2020-2031

1.4.2 Global Dutasteride Sales 2020-2031

1.4.3 Global Dutasteride Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Dutasteride Market Competition by Manufacturers

2.1 Global Dutasteride Sales Market Share by Manufacturers (2020-2025)

2.2 Global Dutasteride Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Dutasteride Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Dutasteride, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Dutasteride, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Dutasteride, Product Type & Application

2.7 Global Key Manufacturers of Dutasteride, Date of Enter into This Industry

2.8 Global Dutasteride Market Competitive Situation and Trends

2.8.1 Global Dutasteride Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Dutasteride Players Market Share by Revenue

2.8.3 Global Dutasteride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Dutasteride Market Scenario by Region

3.1 Global Dutasteride Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Dutasteride Sales by Region: 2020-2031

3.2.1 Global Dutasteride Sales by Region: 2020-2025

3.2.2 Global Dutasteride Sales by Region: 2026-2031

3.3 Global Dutasteride Revenue by Region: 2020-2031

3.3.1 Global Dutasteride Revenue by Region: 2020-2025

3.3.2 Global Dutasteride Revenue by Region: 2026-2031

3.4 North America Dutasteride Market Facts & Figures by Country

3.4.1 North America Dutasteride Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Dutasteride Sales by Country (2020-2031)

3.4.3 North America Dutasteride Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Dutasteride Market Facts & Figures by Country

3.5.1 Europe Dutasteride Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Dutasteride Sales by Country (2020-2031)

3.5.3 Europe Dutasteride Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Dutasteride Market Facts & Figures by Region

3.6.1 Asia Pacific Dutasteride Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Dutasteride Sales by Region (2020-2031)

3.6.3 Asia Pacific Dutasteride Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Dutasteride Market Facts & Figures by Country

3.7.1 Latin America Dutasteride Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Dutasteride Sales by Country (2020-2031)

3.7.3 Latin America Dutasteride Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Dutasteride Market Facts & Figures by Country

3.8.1 Middle East and Africa Dutasteride Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Dutasteride Sales by Country (2020-2031)

3.8.3 Middle East and Africa Dutasteride Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Dutasteride Sales by Type (2020-2031)

4.1.1 Global Dutasteride Sales by Type (2020-2025)

4.1.2 Global Dutasteride Sales by Type (2026-2031)

4.1.3 Global Dutasteride Sales Market Share by Type (2020-2031)

4.2 Global Dutasteride Revenue by Type (2020-2031)

4.2.1 Global Dutasteride Revenue by Type (2020-2025)

4.2.2 Global Dutasteride Revenue by Type (2026-2031)

4.2.3 Global Dutasteride Revenue Market Share by Type (2020-2031)

4.3 Global Dutasteride Price by Type (2020-2031)

5 Segment by Application

5.1 Global Dutasteride Sales by Application (2020-2031)

5.1.1 Global Dutasteride Sales by Application (2020-2025)

5.1.2 Global Dutasteride Sales by Application (2026-2031)

5.1.3 Global Dutasteride Sales Market Share by Application (2020-2031)

5.2 Global Dutasteride Revenue by Application (2020-2031)

5.2.1 Global Dutasteride Revenue by Application (2020-2025)

5.2.2 Global Dutasteride Revenue by Application (2026-2031)

5.2.3 Global Dutasteride Revenue Market Share by Application (2020-2031)

5.3 Global Dutasteride Price by Application (2020-2031)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Company Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.1.4 GSK Dutasteride Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 Bionpharma

6.2.1 Bionpharma Company Information

6.2.2 Bionpharma Description and Business Overview

6.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Bionpharma Dutasteride Product Portfolio

6.2.5 Bionpharma Recent Developments/Updates

6.3 Rising Pharmaceuticals

6.3.1 Rising Pharmaceuticals Company Information

6.3.2 Rising Pharmaceuticals Description and Business Overview

6.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Rising Pharmaceuticals Dutasteride Product Portfolio

6.3.5 Rising Pharmaceuticals Recent Developments/Updates

6.4 Teva

6.4.1 Teva Company Information

6.4.2 Teva Description and Business Overview

6.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Teva Dutasteride Product Portfolio

6.4.5 Teva Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Company Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Dutasteride Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Zydus

6.6.1 Zydus Company Information

6.6.2 Zydus Description and Business Overview

6.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zydus Dutasteride Product Portfolio

6.6.5 Zydus Recent Developments/Updates

6.7 Amneal Pharma

6.7.1 Amneal Pharma Company Information

6.7.2 Amneal Pharma Description and Business Overview

6.7.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Amneal Pharma Dutasteride Product Portfolio

6.7.5 Amneal Pharma Recent Developments/Updates

6.8 Apotex

6.8.1 Apotex Company Information

6.8.2 Apotex Description and Business Overview

6.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Apotex Dutasteride Product Portfolio

6.8.5 Apotex Recent Developments/Updates

6.9 Marksans Pharma

6.9.1 Marksans Pharma Company Information

6.9.2 Marksans Pharma Description and Business Overview

6.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Marksans Pharma Dutasteride Product Portfolio

6.9.5 Marksans Pharma Recent Developments/Updates

6.10 Breckenridge Pharmaceutical

6.10.1 Breckenridge Pharmaceutical Company Information

6.10.2 Breckenridge Pharmaceutical Description and Business Overview

6.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio

6.10.5 Breckenridge Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Dutasteride Industry Chain Analysis

7.2 Dutasteride Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Dutasteride Production Mode & Process Analysis

7.4 Dutasteride Sales and Marketing

7.4.1 Dutasteride Sales Channels

7.4.2 Dutasteride Distributors

7.5 Dutasteride Customer Analysis

8 Dutasteride Market Dynamics

8.1 Dutasteride Industry Trends

8.2 Dutasteride Market Drivers

8.3 Dutasteride Market Challenges

8.4 Dutasteride Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

GSK

Bionpharma

Rising Pharmaceuticals

Breckenridge Pharmaceutical

List of Tables

Table 1. Global Dutasteride Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Dutasteride Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Dutasteride Market Competitive Situation by Manufacturers in 2024

Table 4. Global Dutasteride Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Dutasteride Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Dutasteride Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Dutasteride Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Dutasteride Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Dutasteride, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Dutasteride, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Dutasteride, Product Type & Application

Table 12. Global Key Manufacturers of Dutasteride, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Dutasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dutasteride as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Dutasteride Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Dutasteride Sales by Region (2020-2025) & (K Units)

Table 18. Global Dutasteride Sales Market Share by Region (2020-2025)

Table 19. Global Dutasteride Sales by Region (2026-2031) & (K Units)

Table 20. Global Dutasteride Sales Market Share by Region (2026-2031)

Table 21. Global Dutasteride Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Dutasteride Revenue Market Share by Region (2020-2025)

Table 23. Global Dutasteride Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Dutasteride Revenue Market Share by Region (2026-2031)

Table 25. North America Dutasteride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Dutasteride Sales by Country (2020-2025) & (K Units)

Table 27. North America Dutasteride Sales by Country (2026-2031) & (K Units)

Table 28. North America Dutasteride Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Dutasteride Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Dutasteride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Dutasteride Sales by Country (2020-2025) & (K Units)

Table 32. Europe Dutasteride Sales by Country (2026-2031) & (K Units)

Table 33. Europe Dutasteride Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Dutasteride Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Dutasteride Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Dutasteride Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Dutasteride Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Dutasteride Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Dutasteride Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dutasteride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Dutasteride Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Dutasteride Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Dutasteride Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Dutasteride Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Dutasteride Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Dutasteride Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Dutasteride Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Dutasteride Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Dutasteride Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Dutasteride Sales (K Units) by Type (2020-2025)

Table 51. Global Dutasteride Sales (K Units) by Type (2026-2031)

Table 52. Global Dutasteride Sales Market Share by Type (2020-2025)

Table 53. Global Dutasteride Sales Market Share by Type (2026-2031)

Table 54. Global Dutasteride Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Dutasteride Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Dutasteride Revenue Market Share by Type (2020-2025)

Table 57. Global Dutasteride Revenue Market Share by Type (2026-2031)

Table 58. Global Dutasteride Price (USD/Unit) by Type (2020-2025)

Table 59. Global Dutasteride Price (USD/Unit) by Type (2026-2031)

Table 60. Global Dutasteride Sales (K Units) by Application (2020-2025)

Table 61. Global Dutasteride Sales (K Units) by Application (2026-2031)

Table 62. Global Dutasteride Sales Market Share by Application (2020-2025)

Table 63. Global Dutasteride Sales Market Share by Application (2026-2031)

Table 64. Global Dutasteride Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Dutasteride Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Dutasteride Revenue Market Share by Application (2020-2025)

Table 67. Global Dutasteride Revenue Market Share by Application (2026-2031)

Table 68. Global Dutasteride Price (USD/Unit) by Application (2020-2025)

Table 69. Global Dutasteride Price (USD/Unit) by Application (2026-2031)

Table 70. GSK Company Information

Table 71. GSK Description and Business Overview

Table 72. GSK Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. GSK Dutasteride Product

Table 74. GSK Recent Developments/Updates

Table 75. Bionpharma Company Information

Table 76. Bionpharma Description and Business Overview

Table 77. Bionpharma Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Bionpharma Dutasteride Product

Table 79. Bionpharma Recent Developments/Updates

Table 80. Rising Pharmaceuticals Company Information

Table 81. Rising Pharmaceuticals Description and Business Overview

Table 82. Rising Pharmaceuticals Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Rising Pharmaceuticals Dutasteride Product

Table 84. Rising Pharmaceuticals Recent Developments/Updates

Table 85. Teva Company Information

Table 86. Teva Description and Business Overview

Table 87. Teva Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Teva Dutasteride Product

Table 89. Teva Recent Developments/Updates

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Dutasteride Product

Table 94. Mylan Recent Developments/Updates

Table 95. Zydus Company Information

Table 96. Zydus Description and Business Overview

Table 97. Zydus Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Zydus Dutasteride Product

Table 99. Zydus Recent Developments/Updates

Table 100. Amneal Pharma Company Information

Table 101. Amneal Pharma Description and Business Overview

Table 102. Amneal Pharma Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Amneal Pharma Dutasteride Product

Table 104. Amneal Pharma Recent Developments/Updates

Table 105. Apotex Company Information

Table 106. Apotex Description and Business Overview

Table 107. Apotex Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Apotex Dutasteride Product

Table 109. Apotex Recent Developments/Updates

Table 110. Marksans Pharma Company Information

Table 111. Marksans Pharma Description and Business Overview

Table 112. Marksans Pharma Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Marksans Pharma Dutasteride Product

Table 114. Marksans Pharma Recent Developments/Updates

Table 115. Breckenridge Pharmaceutical Company Information

Table 116. Breckenridge Pharmaceutical Description and Business Overview

Table 117. Breckenridge Pharmaceutical Dutasteride Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Breckenridge Pharmaceutical Dutasteride Product

Table 119. Breckenridge Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Dutasteride Distributors List

Table 123. Dutasteride Customers List

Table 124. Dutasteride Market Trends

Table 125. Dutasteride Market Drivers

Table 126. Dutasteride Market Challenges

Table 127. Dutasteride Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Dutasteride

Figure 2. Global Dutasteride Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dutasteride Market Share by Type: 2024 & 2031

Figure 4. Type I Product Picture

Figure 5. Type II Product Picture

Figure 6. Global Dutasteride Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Dutasteride Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Drug Store

Figure 10. Global Dutasteride Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Dutasteride Market Size (2020-2031) & (US$ Million)

Figure 12. Global Dutasteride Sales (2020-2031) & (K Units)

Figure 13. Global Dutasteride Average Price (USD/Unit) & (2020-2031)

Figure 14. Dutasteride Report Years Considered

Figure 15. Dutasteride Sales Share by Manufacturers in 2024

Figure 16. Global Dutasteride Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Dutasteride Players: Market Share by Revenue in Dutasteride in 2024

Figure 18. Dutasteride Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Dutasteride Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Dutasteride Sales Market Share by Country (2020-2031)

Figure 21. North America Dutasteride Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Dutasteride Sales Market Share by Country (2020-2031)

Figure 25. Europe Dutasteride Revenue Market Share by Country (2020-2031)

Figure 26. Germany Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Dutasteride Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Dutasteride Revenue Market Share by Region (2020-2031)

Figure 33. China Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Taiwan Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Philippines Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Dutasteride Sales Market Share by Country (2020-2031)

Figure 44. Latin America Dutasteride Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Dutasteride Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Dutasteride Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Dutasteride Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Dutasteride by Type (2020-2031)

Figure 54. Global Revenue Market Share of Dutasteride by Type (2020-2031)

Figure 55. Global Dutasteride Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Dutasteride by Application (2020-2031)

Figure 57. Global Revenue Market Share of Dutasteride by Application (2020-2031)

Figure 58. Global Dutasteride Price (USD/Unit) by Application (2020-2031)

Figure 59. Dutasteride Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions